Corrine Savill, Acting Chief Business Officer at Cullinan Oncology, Inc. (CGEM), sold 40,000 shares at $15.06 ($607K) on 2022-07-18, disclosed to the SEC on 2022-07-21.
Open-market sale of $607k CGEM by Acting Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.06 | 5,042 | $76K | 12.5% |
| 2 | $15.06 | 5,042 | $76K | 12.5% |
| 3 | $15.22 | 14,958 | $228K | 37.5% |
| 4 | $15.22 | 14,958 | $228K | 37.5% |
| Total | $15.18 avg | 40,000 | $607K | 100% |
| Filing → |
| CGEM | SELL | 2024-01-24 | $935K | — | Filing → |
| CGEM | SELL | 2022-07-12 | $533K | — | Filing → |